Proteomic analysis of up-regulated proteins in human promonocyte cells expressing severe acute respiratory syndrome coronavirus 3C-like protease
- PMID: 17407183
- PMCID: PMC7167764
- DOI: 10.1002/pmic.200600459
Proteomic analysis of up-regulated proteins in human promonocyte cells expressing severe acute respiratory syndrome coronavirus 3C-like protease
Abstract
The pathogenesis of severe acute respiratory syndrome coronavirus (SARS CoV) is an important issue for treatment and prevention of SARS. Previously, SARS CoV 3C-like protease (3CLpro) has been demonstrated to induce apoptosis via the activation of caspase-3 and caspase-9 (Lin, C. W., Lin, K. H., Hsieh, T. H., Shiu, S. Y. et al., FEMS Immunol. Med. Microbiol. 2006, 46, 375-380). In this study, proteome analysis of the human promonocyte HL-CZ cells expressing SARS CoV 3CLpro was performed using 2-DE and nanoscale capillary LC/ESI quadrupole-TOF MS. Functional classification of identified up-regulated proteins indicated that protein metabolism and modification, particularly in the ubiquitin proteasome pathway, was the main biological process occurring in SARS CoV 3CLpro-expressing cells. Thirty-six percent of identified up-regulated proteins were located in the mitochondria, including apoptosis-inducing factor, ATP synthase beta chain and cytochrome c oxidase. Interestingly, heat shock cognate 71-kDa protein (HSP70), which antagonizes apoptosis-inducing factor was shown to down-regulate and had a 5.29-fold decrease. In addition, confocal image analysis has shown release of mitochondrial apoptogenic apoptosis-inducing factor and cytochrome c into the cytosol. Our results revealed that SARS CoV 3CLpro could be considered to induce mitochondrial-mediated apoptosis. The study provides system-level insights into the interaction of SARS CoV 3CLpro with host cells, which will be helpful in elucidating the molecular basis of SARS CoV pathogenesis.
The pathogenesis of severe acute respiratory syndrome coronavirus (SARS CoV) is an important issue for treatment and prevention of SARS. Previously, SARS CoV 3C‐like protease (3CLpro) has been demonstrated to induce apoptosis via the activation of caspase‐3 and caspase‐9 (Lin, C. W., Lin, K. H., Hsieh, T. H., Shiu, S. Y. et al., FEMS Immunol. Med. Microbiol. 2006, 46, 375–380). In this study, proteome analysis of the human promonocyte HL‐CZ cells expressing SARS CoV 3CLpro was performed using 2‐DE and nanoscale capillary LC/ESI quadrupole‐TOF MS. Functional classification of identified up‐regulated proteins indicated that protein metabolism and modification, particularly in the ubiquitin proteasome pathway, was the main biological process occurring in SARS CoV 3CLpro‐expressing cells. Thirty‐six percent of identified up‐regulated proteins were located in the mitochondria, including apoptosis‐inducing factor, ATP synthase beta chain and cytochrome c oxidase. Interestingly, heat shock cognate 71‐kDa protein (HSP70), which antagonizes apoptosis‐inducing factor was shown to down‐regulate and had a 5.29‐fold decrease. In addition, confocal image analysis has shown release of mitochondrial apoptogenic apoptosis‐inducing factor and cytochrome c into the cytosol. Our results revealed that SARS CoV 3CLpro could be considered to induce mitochondrial‐mediated apoptosis. The study provides system‐level insights into the interaction of SARS CoV 3CLpro with host cells, which will be helpful in elucidating the molecular basis of SARS CoV pathogenesis.
Similar articles
-
Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis.FEMS Immunol Med Microbiol. 2006 Apr;46(3):375-80. doi: 10.1111/j.1574-695X.2006.00045.x. FEMS Immunol Med Microbiol. 2006. PMID: 16553810 Free PMC article.
-
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29. Antiviral Res. 2015. PMID: 25554382 Free PMC article. Review.
-
Correlation between TGF-β1 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain-like protease.Proteomics. 2012 Nov;12(21):3193-205. doi: 10.1002/pmic.201200225. Epub 2012 Oct 5. Proteomics. 2012. PMID: 22936401 Free PMC article.
-
Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs.FEBS Lett. 2004 Sep 10;574(1-3):131-7. doi: 10.1016/j.febslet.2004.08.017. FEBS Lett. 2004. PMID: 15358553 Free PMC article.
-
Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases.FEBS J. 2021 Sep;288(17):5089-5121. doi: 10.1111/febs.15696. Epub 2021 Feb 1. FEBS J. 2021. PMID: 33400393 Review.
Cited by
-
Proteomics analysis of differentially expressed proteins in chicken trachea and kidney after infection with the highly virulent and attenuated coronavirus infectious bronchitis virus in vivo.Proteome Sci. 2012 Mar 31;10:24. doi: 10.1186/1477-5956-10-24. Proteome Sci. 2012. PMID: 22463732 Free PMC article.
-
Human coronaviruses: Clinical features and phylogenetic analysis.Biomedicine (Taipei). 2013 Mar;3(1):43-50. doi: 10.1016/j.biomed.2012.12.007. Epub 2013 Feb 1. Biomedicine (Taipei). 2013. PMID: 32289002 Free PMC article. Review.
-
The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors.PLoS Pathog. 2020 Nov 2;16(11):e1009013. doi: 10.1371/journal.ppat.1009013. eCollection 2020 Nov. PLoS Pathog. 2020. PMID: 33137165 Free PMC article. Review.
-
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.iScience. 2020 Oct 23;23(10):101631. doi: 10.1016/j.isci.2020.101631. Epub 2020 Sep 29. iScience. 2020. PMID: 33015593 Free PMC article. Review.
-
The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19.J Clin Med. 2020 Oct 30;9(11):3518. doi: 10.3390/jcm9113518. J Clin Med. 2020. PMID: 33143379 Free PMC article. Review.
References
-
- Lee, N. , Hui, D. , Wu, A. , Chan, P. et al., N. Engl. J. Med. 2003, 348, 1986–1994. - PubMed
-
- Tsang, K. W. , Ho, P. L. , Ooi, G. C. , Yee, W. K. et al., N. Engl. J. Med. 2003, 348, 1977–1985. - PubMed
-
- Hsueh, P. R. , Chen, P. J. , Hsiao, C. H. , Yeh, S. H. et al., Emerg. Infect. Dis. 2004, 10, 489–493. - PubMed
-
- Lang, Z. , Zhang, L. , Zhang, S. , Meng, X. et al., Chin Med J (Engl). 2003, 116, 976–980. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous